1 hpc in dr hpc in drug ug disco discover ery
play

1 HPC in Dr HPC in Drug ug Disco Discover ery Ashutosh - PowerPoint PPT Presentation

1 HPC in Dr HPC in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Technologies in Drug Discovery Chemistry Lab based HPC MD-based Simulations Expensive


  1. 1

  2. HPC in Dr HPC in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Technologies in Drug Discovery Chemistry Lab based HPC MD-based Simulations • Expensive • Inexpensive • Protracted • Very fast • Difficult • Useful for early stages HPC in Drug Discovery 2

  3. HPC in Dr HPC in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC In silico Screening Complements High-throughput Screening Structure-based & Ligand-based screens Chemical database N=1,000,000 Absorption Distribution Affinity Metabolism Selectivity Drug-like? Excretion Activity Toxicity Computational Tools: • DESMOND • GROMACS Lead candidates Inactive • CHARMM N=500 • SCHRODINGER . . . 3 HPC in Drug Discovery

  4. HPC in Dr HPC in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Drug Discovery: Driven by Computation and Experiments Drug Discovery HPC in Drug Discovery 4

  5. Phosphatidylinositol Transfer Proteins (PITPs) Important in Cell Function  Important in Lipid-mediated cell signaling and metabolism.  Derangement in Signaling: Neurodegenerative diseases and many forms of cancers. Lipid exchange at binding cavity Drug Membrane docking. PI/PC Lipid Drug binding to Dynamic Gate Signaling molecule Sec14-PITP cavity Cell membrane 5 HPC in Drug Discovery

  6. Phosphatidylinositol Transfer Proteins (PITPs) Critical in Cell Function • Important in Lipid-mediated cell signaling and metabolism. • Derangement in Signaling: Neurodegenerative diseases and many forms of cancers. • Undergoes Conformational Changes: Helical Gate Mediates Lipid Access/Exchange Gate Sec14-OPEN CLOSED HPC in Drug Discovery ‘Transition state’? 6 Schaaf et. al. Mol. Cell. (2008)

  7. HPC in Dr HPC in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Homology Modeling of Sec14 (Closed Conformation) • Sec14 is a PITP protein; • It’s binding to the PI and PC lipids is studied using the SCHRODINGER & DESMOND MD codes Sec14-OPEN Sfh1-CLOSED (Sec14 homolog) Yellow: Sfh1 Blue: Sec14-OPEN Identity: 62 % Red: Sec14 Homology Model-CLOSED Similarity: 78 % HPC in Drug Discovery 7 Homology: 77 %

  8. Docking-Based Virtual Screening VALIDATED SCORING & DOCKING RANKING MODELS Ligands + decoys Target Structure Docking High HITS (confirmed Score actives) ~10 6 – 10 9 molecules CHEMICAL DATABASE INACTIVES Decoys: known or presumed non-binders to the target protein. 8 HPC in Drug Discovery

  9. HPC HPC in Dr in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Sec14 Homology Model: All-Atom MD Simulation HPC in Drug Discovery 9

  10. HPC HPC in Dr in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Simulation of Drug Binding to Protein Using DESMOND MD Code HPC in Drug Discovery 10

  11. All-Atom Simulation of Sec14 in Explicit Water Molecules (used DESMOND MD Code) HPC in Drug Discovery 11

  12. HPC HPC in Dr in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Small molecule (drug) vibrating in Sec14 binding pocket (Used DESMOND MD Code) HPC in Drug Discovery 12

  13. HPC HPC in Dr in Drug ug Disco Discover ery Ashutosh Tripathi, Ph.D. Bankaitis Lab Department of Molecular and Cellular Medicine, TAMHSC Conclusion HPC in Drug Discovery 13

  14. Ashutosh Tripathi, Ph.D.  Ph.D. (Pharmaceutical Sciences), Department of Medicinal Chemistry, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, U.S.A.  Master of Science in Cheminformatics, Department of Chemistry, University of Manchester, U.K.  Bachelor of Pharmacy, Institute of Engineering and Technology, M.J.P. Rohilkhand University, India. Research Interest  Computer-aided drug design.  Algorithm and software development for designing new drugs.  Cancer therapeutics.  Clinical informatics.  ADME/Tox QSAR modeling. 14 HPC in Drug Discovery

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend